Table 2: Total antibodies in saliva of immunodeficient patients and controls.

 

Groups Mean ± SD

 Significance

Control (n = 37)

CVID (n = 19)

NS (n = 19)

p

post-hoc

Saliva IgG

256.88 ± 103.22

171.50 ± 88.07

140.50 ± 96.90

< 0.001

1-2, 1-3

Saliva IgA

0.82 ± 0.34

0.70 ± 0.39

0.77 ± 0.46

0.519

 

Saliva IgM

1.04 ± 0.31

0.86 ± 0.52

0.95 ± 0.35

0.738